Market Tracker

04/26 5:16pm ET

OPKO Health Inc (NASDAQ:OPK)

7.83
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
7.11
Today|||52-Week Range
12.15
-15.81%
Year-to-Date
Weekly CEO Buys Highlights
Apr 24 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close7.83
Today’s open7.78
Day’s range7.76 - 7.88
Volume2,625,865
Average volume (3 months)4,831,166
Market cap$4.4B
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-136.00%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+2.67+5.20%
AGNPRAAllergan plc+2.32+0.27%
ACADACADIA Pharmaceutica...-1.05-3.03%
AKRXAkorn Inc+0.09+0.27%
Data as of 4:02pm ET, 04/26/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts